Conditional Survival with Time of Overall Survival and Disease-free Survival for Mid or Low Locally Advanced Rectal Cancer

Author:

Wang Guancong1,Li Jiasen,Zeng Qunzhang1,Huang Ying2,Guo Yincong1

Affiliation:

1. Zhangzhou Affiliated Hospital of Fujian Medical University

2. Fujian Medical University Union Hospital

Abstract

Abstract Aim To evaluate the changes of conditional survival (CS) for mid or low locally advanced rectal cancer (LARC) and to determine how the prognostic factors affecting CS evolve over time. Methods We analyzed data of 1833 patients from two centers. Kaplan-Meier and multivariate Cox regression were used to calculate conditional disease-free survival (cDFS) and conditional overall survival (cOS). Multivariable Cox regression models were used to calculate proportional hazard ratios (HR) for the prediction of cDFS and cOS. Funding The 5-year OS and DFS estimates were 83.3% and 78.3%, respectively. Given a 1-, 2-, 3-, 4- and 5-year survivorship, the 5-year cOS rates increased to 83.7%, 85.0%, 85.8%, 89.1%, and 92.6%, respectively. Similarly, given a 1-, 2-, 3-, 4- and 5-year disease-free survivorship, the 5-year cDFS rates increased to 81.8%, 86.0%, 88.3%, 92.3%, and 94.6%, respectively. The impact of well-known prognostic factors on CS estimates relevance changed or even disappeared over time. Whereas distance to the anal verge (DTAV) and neoadjuvant rectal (NAR) score was the most stable and reliable prognostic factors for CS. Independent effects of NAR score (HRs 1.68, 1.85, 2.10, 1.99, 3.38, respectively) and DTAV (HRs 0.48, 0.52, 0.52, 0.47, 0.34, respectively) factors on cOS can be found, at all-time points including baseline, 1, 2, 3, and 4 years. Interestingly, a consistent independent effect of NAR (HRs 1.71, 1.89, 1.83, 1.84, 2.78, respectively) score on cDFS at baseline, 1, 2, 3, and 4 years survived, and DTAV (HRs 0.51, 0.61, 0.62, 0.45, respectively) on cDFS at survived for within 3 years. The stratified analysis revealed that the lower the DTAV or higher the NAR score, the lower the 5-year CS probability over the entire time after surgery, which supports the results of multifactorial Cox regression. Conclusions CS rates increase over time in LARC patients, especially in patients with long-term survival. Factors of influence may change with prolonged survival, DTAV and NAR score were persistent predictors of long-term prognosis.

Publisher

Research Square Platform LLC

Reference25 articles.

1. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology;Benson AB;J Natl Compr Canc Netw,2018

2. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): 10-year follow-up of an open-label, non-inferiority, randomised controlled trial;Park JW;Lancet Gastroenterol Hepatol,2021

3. A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer;Li Y;Int J Biol Sci,2016

4. Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers;Peng JY;World J Gastroenterol,2013

5. Development and validation of neoadjuvant rectal score-based signature nomograms to predict overall survival and disease-free survival in locally advanced rectal cancer: a retrospective, double center, cohort study;Wang G;Int J Clin Oncol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3